SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-23-064829
Filing Date
2023-11-17
Accepted
2023-11-17 16:19:56
Documents
13
Period of Report
2023-11-16
Items
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K cytk-20231116.htm   iXBRL 8-K 52615
2 EX-3.1 cytk-ex3_1.htm EX-3.1 258469
  Complete submission text file 0000950170-23-064829.txt   466424

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT cytk-20231116.xsd EX-101.SCH 2469
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT cytk-20231116_lab.xml EX-101.LAB 14019
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT cytk-20231116_pre.xml EX-101.PRE 10287
7 EXTRACTED XBRL INSTANCE DOCUMENT cytk-20231116_htm.xml XML 4934
Mailing Address 350 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080
Business Address 350 OYSTER POINT BOULEVARD . SOUTH SAN FRANCISCO CA 94080 (650) 624-3000
CYTOKINETICS INC (Filer) CIK: 0001061983 (see all company filings)

IRS No.: 943291317 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-50633 | Film No.: 231418991
SIC: 2834 Pharmaceutical Preparations